Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TREPHIX THREE PHSE GENERATORS AND EXONON SINGLE PHASE GENERATORS

K-Number: K837180 · 1983-03-17

ApplicantElscint, Inc.
Decision Date1983-03-17
Product Code
DecisionSubstantially Equivalent

Device Summary

TREPHIX THREE PHSE GENERATORS AND EXONON SINGLE PHASE GENERATORS is the device name listed in this FDA 510(k) record. The listed applicant is Elscint, Inc.. It received FDA 510(k) clearance on 1983-03-17 under 510(k) number K837180. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TREPHIX THREE PHSE GENERATORS AND EXONON SINGLE PHASE GENERATORS?

TREPHIX THREE PHSE GENERATORS AND EXONON SINGLE PHASE GENERATORS is a medical device that received FDA 510(k) clearance on 1983-03-17. The listed applicant is Elscint, Inc.. The 510(k) number is K837180.

When did TREPHIX THREE PHSE GENERATORS AND EXONON SINGLE PHASE GENERATORS receive FDA 510(k) clearance?

TREPHIX THREE PHSE GENERATORS AND EXONON SINGLE PHASE GENERATORS received FDA 510(k) clearance on 1983-03-17, under 510(k) number K837180.

Who is the listed applicant for TREPHIX THREE PHSE GENERATORS AND EXONON SINGLE PHASE GENERATORS?

The FDA 510(k) record lists Elscint, Inc. as the applicant. This does not by itself establish the device manufacturer.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Elscint, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K983313ADVANCED AUTOMATIC DETECTOR SELECTION OPTION FOR GLORYK982060VOLUMAX CT IMAGING SYSTEMK974344CT SCOPEK980306GYREX 2T PRESTIGE, GYREX PRIMA ITG, GYREX PRIVILEGE, GYREX V-EPK974614GYREX 2T PRESTIGE 100-6321-0107, GYREX PRIVILEDGE 100-6326-0102, GYREX PRIMA 1TG 100-6250-0102K9725922T PRESTIGE(100-6321-0107)/PRIVILEGE(100-6326-0102)/GYREX V-EP(100-6327-0101)

View all 94 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑